Articles From: Aeterna Zentaris to Announce Fourth Quarter and Full Year 2012 Financial and Operating Results on March 21, 2013 to Aetna Announces Leadership Changes in Line with Growth Strategy


2013/3/12
QUEBEC CITY , March 12, 2013 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") will announce its fourth quarter and full-year 2012 financial and operating results on Thursday, March 21, 2013 , after market close.
Sign-up for Aeterna Zentaris to Announce Fourth Quarter and Full Year 2012 Financial and Operating Results on March 21, 2013 investment picks
2013/3/12
Aeterna Zentaris to Announce Fourth Quarter and Full Year 2012 Financial and Operating Results on March 21, 2013 Canada NewsWire QUEBEC CITY, March 12, 2013 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") will announce its fourth quarter and full-year 2012 financial and operating results on Thursday, March 21, 2013 , after market close.
Sign-up for Aeterna Zentaris to Announce Fourth Quarter and Full Year 2012 Financial and Operating Results on March 21, 2013 investment picks
2013/3/11
Aeterna Zentaris to Discontinue Phase 3 Trial in Multiple Myeloma with Perifosine Following Data Safety Monitoring Board Recommendation Canada NewsWire QUEBEC CITY, March 11, 2013 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that an independent Data Safety Monitoring Board ("DSMB") has recommended discontinuing the ongoing Phase 3 study comparing the efficacy and safety of perifosine to placebo when combined with bortezomib (Velcade ® ) and dexamethasone in patients with relapsed or relapsed/refractory multiple myeloma.
Sign-up for Aeterna Zentaris to Discontinue Phase 3 Trial in Multiple Myeloma with Perifosine Following Data Safety Monitoring Board Recommendation investment picks
2013/3/11
QUEBEC CITY , March 11, 2013 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that an independent Data Safety Monitoring Board ("DSMB") has recommended discontinuing the ongoing Phase 3 study comparing the efficacy and safety of perifosine to placebo when combined with bortezomib (Velcade ® ) and dexamethasone in patients with relapsed or relapsed/refractory multiple myeloma.
Sign-up for Aeterna Zentaris to Discontinue Phase 3 Trial in Multiple Myeloma with Perifosine Following Data Safety Monitoring Board Recommendation investment picks
2013/5/15
Aeterna Zentaris to Present at Upcoming Bloom Burton & Co.
Sign-up for Aeterna Zentaris to Present at Upcoming Bloom Burton & Co. Healthcare Investor Conference in Toronto investment picks
2013/5/15
QUÉBEC CITY, May 15, 2013 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that the Company's Senior Vice President and CFO, Dennis Turpin CPA CA, will be presenting a corporate overview at the Bloom Burton & Co.
Sign-up for Aeterna Zentaris to Present at Upcoming Bloom Burton & Co. Healthcare Investor Conference in Toronto investment picks
2013/3/13
QUÉBEC CITY, March 13, 2013 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that its President and CEO, Juergen Engel , PhD, will be presenting a corporate overview at the Roth 25 th Annual OC Growth Stock Conference on Tuesday, March 19, 2013 , at 9:30 am (Pacific), in Track 6: Salon 5-Pink of the Ritz Carlton hotel in Dana Point, California .
Sign-up for Aeterna Zentaris to Present at Upcoming Roth 25th Annual OC Growth Stock Conference investment picks
2013/3/13
Aeterna Zentaris to Present at Upcoming Roth 25th Annual OC Growth Stock Conference Canada NewsWire QUÉBEC CITY, March 13, 2013 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that its President and CEO, Juergen Engel, PhD, will be presenting a corporate overview at the Roth 25 th Annual OC Growth Stock Conference on Tuesday, March 19, 2013 , at 9:30 am (Pacific), in Track 6: Salon 5-Pink of the Ritz Carlton hotel in Dana Point , California.
Sign-up for Aeterna Zentaris to Present at Upcoming Roth 25th Annual OC Growth Stock Conference investment picks
2013/4/3
Aeterna Zentaris to Present Update on its LHRH Receptor-Targeted Disorazol Z Cytotoxic Conjugates at Upcoming AACR Annual Meeting Canada NewsWire SOURCE: AETERNA ZENTARIS INC.
Sign-up for Aeterna Zentaris to Present Update on its LHRH Receptor-Targeted Disorazol Z Cytotoxic Conjugates at Upcoming AACR Annual Meeting investment picks
2013/4/3
QUÉBEC CITY, April 3, 2013 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that Babette Aicher , PhD, Director of Preclinical Development, will be making a poster presentation on updated proof-of-concept results for Disorazol Z cytotoxic conjugates, such as AEZS-125 and AEZS-138, in human ovarian and endometrial cancer xenograft models, at the upcoming American Association for Cancer Research ("AACR") annual meeting, which will be held April 6-10, 2013 , in Washington D.C. The study is funded through a grant from the German Ministry of Education and Research.
Sign-up for Aeterna Zentaris to Present Update on its LHRH Receptor-Targeted Disorazol Z Cytotoxic Conjugates at Upcoming AACR Annual Meeting investment picks
2013/2/20
Aeterna Zentaris: First Patient Treated for Phase 2 Trial with AEZS-108 in Triple-Negative Breast Cancer Canada NewsWire QUÉBEC CITY, Feb.
Sign-up for Aeterna Zentaris: First Patient Treated for Phase 2 Trial with AEZS-108 in Triple-Negative Breast Cancer investment picks
2013/2/20
QUÉBEC CITY, Feb.
Sign-up for Aeterna Zentaris: First Patient Treated for Phase 2 Trial with AEZS-108 in Triple-Negative Breast Cancer investment picks
2013/4/18
SAN DIEGO , April 18, 2013 /PRNewswire/ -- Aethlon Medical, Inc. (OTCBB: AEMD) , disclosed that a poster presentation entitled: "Extracorporeal Exosome Removal: A Therapeutic Strategy to Address an Evolutionary Survival Mechanism Shared by Cancer and Infectious Viral Pathogens," is being presented today at the International Society of Extracellular Vesicles  (ISEV) 2013 conference being held in Boston , MA.
Sign-up for Aethlon Medical Discloses Cancer and Infectious Disease Therapy Presentation at ISEV 2013 investment picks
2013/1/29
SAN DIEGO , Jan.
Sign-up for Aethlon Medical Discloses CEO Interview investment picks
2013/2/11
Company invites individual and institutional investors to log-on to view presentation NEW YORK , Feb.
Sign-up for Aethlon Medical, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com investment picks
2013/5/7
HOUSTON, May 7, 2013 (GLOBE NEWSWIRE) -- American Electric Technologies, Inc. (Nasdaq:AETI) a leading supplier of power delivery solutions for the global energy industry, today announced its 2013 first quarter results.
Sign-up for AETI Announces 395% Increase in First Quarter Net Income investment picks
2013/3/5
HOUSTON, March 5, 2013 (GLOBE NEWSWIRE) -- American Electric Technologies, Inc. (Nasdaq:AETI) , a leading supplier of power delivery solutions for the global energy industry, today announced its 2012 fourth quarter and annual results.
Sign-up for AETI Announces Quarterly Financial Growth, Improved Annual Results investment picks
2013/5/6
HOUSTON, May 6, 2013 (GLOBE NEWSWIRE) -- American Electric Technologies, Inc. (Nasdaq:AETI) , a leading supplier of power delivery solutions for the global energy industry, today announced it will begin offering arc-resistant switchgear allowing end users to create safer work environments, comply with electrical regulations for the workplace, and better protect lives and assets.
Sign-up for AETI Extends Product Portfolio to Include Arc-Resistant Switchgear investment picks
2013/2/26
HOUSTON, Feb.
Sign-up for AETI Names Troy Coker Director of Sales for Upstream Oil and Gas Market investment picks
2013/4/30
Aetna Inc.'s (AET) first-quarter earnings fell 4.1%, partly due to integration and other charges, while the health insurer's revenue and membership rolls increased.
Sign-up for Aetna 1st-Quarter Net Falls 4.1% on Charges; Raises Year View investment picks
2013/4/8
Aetna Employee Assistance Program (EAP) members may now have access to a social networking platform that connects them to peer support and behavior change professionals for help in overcoming chronic behavioral health conditions such as alcoholism, depression or stress.
Sign-up for Aetna Adds OneHealth® Peer Support Platform to Employee Assistance Program to Help Members Change Behaviors investment picks
2013/3/27
Aetna (NYSE: AET ) and Best Doctors, Inc. ® announced today a strategic alliance that will offer Aetna Medicare Advantage participants in the Teacher Retirement System of Texas (TRS) access to the medical expertise of Best Doctors’ highest-ranked five percent of medical experts in the world.
Sign-up for Aetna and Best Doctors, Inc. Form Innovative Alliance to Provide Teacher Retirement System of Texas Retirees and Their Dependents Expert Medical Support investment picks
2013/2/14
Aetna (NYSE: AET ) and PatientsLikeMe today announced a new program to help Aetna members improve the way they live with various health conditions.
Sign-up for Aetna and PatientsLikeMe Help Empower Members Through Collaborative Program investment picks
2013/1/29
Aetna (NYSE: AET ) and Texas Health Resources today announced a new accountable care agreement in the Dallas – Fort Worth Metroplex.
Sign-up for Aetna and Texas Health Resources Form Accountable Care Collaboration investment picks
2013/2/7
Aetna’s (NYSE: AET ) annual meeting of shareholders will occur on Friday, May 17, 2013.
Sign-up for Aetna Announces 2013 Annual Meeting Will Be Held May 17 in Tampa, Florida investment picks
2013/2/20
Aetna (NYSE: AET ) announced today that Shawn M.
Sign-up for Aetna Announces Appearance at 2013 Citi Global Health Care Conference investment picks
2013/3/7
Aetna (NYSE: AET ) announced today that Joseph M.
Sign-up for Aetna Announces Appearance at Barclays Capital 2013 Global Healthcare Conference investment picks
2013/5/10
Aetna (NYSE: AET ) announced today that Thomas F.
Sign-up for Aetna Announces Appearance at the Bank of America Merrill Lynch Health Care Conference investment picks
2013/1/31
Aetna (NYSE: AET ) today announced changes to its executive leadership team as part of the company’s growth strategy and a continuing effort to align its businesses with the evolving needs of its customers.
Sign-up for Aetna Announces Leadership Changes in Line with Growth Strategy investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Aeterna Zentaris to Announce Fourth Quarter and Full Year 2012 Financial and Operating Results on March 21, 2013 to Aetna Announces Leadership Changes in Line with Growth Strategy
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity